91 related articles for article (PubMed ID: 20436453)
21. Genetic loading on human loving styles.
Emanuele E; Brondino N; Pesenti S; Re S; Geroldi D
Neuro Endocrinol Lett; 2007 Dec; 28(6):815-21. PubMed ID: 18063936
[TBL] [Abstract][Full Text] [Related]
22. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
23. [Genomics in psychology and psychiatry].
Golimbet VE
Mol Biol (Mosk); 2004; 38(1):165-70. PubMed ID: 15042846
[TBL] [Abstract][Full Text] [Related]
24. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
[TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
Xu MQ; St Clair D; Ott J; Feng GY; He L
Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
[TBL] [Abstract][Full Text] [Related]
26. Association of 5-HTTLPR serotonin transporter gene polymorphism and Val66Met brain-derived neurotrophic factor gene polymorphism with auditory N100 evoked potential amplitude in patients with endogenous psychoses.
Golimbet VE; Lebedeva IS; Korovaitseva GI; Lezheiko TV; Yumatova PE
Bull Exp Biol Med; 2008 Nov; 146(5):605-8. PubMed ID: 19526102
[TBL] [Abstract][Full Text] [Related]
27. Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.
Contreras J; Hernández S; Quezada P; Dassori A; Walss-Bass C; Escamilla M; Raventos H
J Neurogenet; 2010 Jul; 24(2):83-9. PubMed ID: 20397838
[TBL] [Abstract][Full Text] [Related]
28. [The moderating effect of the Va166Met polymorphism of brain-derived neurotrophic factor gene on the clinical and psychological features of patients with schizophrenia].
golimbet VE; Alfimova MV; Korovaĭtseva GI; Lezheĭko TV
Mol Biol (Mosk); 2014; 48(1):81-8. PubMed ID: 25842828
[TBL] [Abstract][Full Text] [Related]
29. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacogenetics and treatment response in schizophrenia].
Moulier V; Januel D
Encephale; 2007 Dec; 33(6):954-64. PubMed ID: 18789788
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an association between brain-derived neurotrophic factor Val66Met gene polymorphism and general intellectual ability in early-onset schizophrenia.
Vyas NS; Puri BK
Isr J Psychiatry Relat Sci; 2012; 49(2):137-42. PubMed ID: 22801293
[TBL] [Abstract][Full Text] [Related]
32. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
[TBL] [Abstract][Full Text] [Related]
33. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
[TBL] [Abstract][Full Text] [Related]
34. Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders.
Chotai J; Serretti A; Lorenzi C
Neuropsychobiology; 2005; 51(1):3-9. PubMed ID: 15627807
[TBL] [Abstract][Full Text] [Related]
35. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
36. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene.
Vincze I; Perroud N; Buresi C; Baud P; Bellivier F; Etain B; Fournier C; Karege F; Matthey ML; Preisig M; Leboyer M; Malafosse A
Bipolar Disord; 2008 Jul; 10(5):580-7. PubMed ID: 18657242
[TBL] [Abstract][Full Text] [Related]
37. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
[TBL] [Abstract][Full Text] [Related]
38. Effects of serotonin transporter promoter and BDNF Val66Met genotype on personality traits in a population representative sample of adolescents.
Hiio K; Merenäkk L; Nordquist N; Parik J; Oreland L; Veidebaum T; Harro J
Psychiatr Genet; 2011 Oct; 21(5):261-4. PubMed ID: 21206400
[TBL] [Abstract][Full Text] [Related]
39. Association analysis of serotonin 2A receptor gene T102c polymorphism and schizophrenia.
Czerski PM; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Kapelski P; Godlewski S; Rybakowski J; Hauser J
World J Biol Psychiatry; 2003 Apr; 4(2):69-73. PubMed ID: 12692777
[TBL] [Abstract][Full Text] [Related]
40. Association between the T102C polymorphism of the serotonin-2A receptor gene and schizophrenia.
Vaquero Lorenzo C; Baca-Garcia E; Diaz-Hernandez M; Botillo-Martin C; Perez-Rodriguez MM; Fernandez-Ramos C; Saiz-Gonzalez MD; Quintero-Gutierrez FJ; Saiz-Ruiz J; Fernandez Piqueras J; Gonzalez de Rivera JL; de Leon J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1136-8. PubMed ID: 16762472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
